Citation Impact
Citing Papers
Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy
2012
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
2004 StandoutScience
Requirement of bic/microRNA-155 for Normal Immune Function
2007 StandoutScience
A microRNA expression signature of human solid tumors defines cancer gene targets
2006 Standout
Helicobacter pylori Cytotoxin-Associated Gene A Activates the Signal Transducer and Activator of Transcription 3 Pathway In vitro and In vivo
2009
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
2013 StandoutNobel
miR-15 and miR-16 induce apoptosis by targeting BCL2
2005 Standout
High burden and pervasive positive selection of somatic mutations in normal human skin
2015 StandoutScience
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Signalling and survival pathways in multiple myeloma
2006
Notch Signaling in the Regulation of Stem Cell Self-Renewal and Differentiation
2010
Mouse Fbw7/Sel-10/Cdc4 Is Required for Notch Degradation during Vascular Development
2004
IKKα, IKKβ, and NEMO/IKKγ Are Each Required for the NF-κB-mediated Inflammatory Response Program
2002
Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
2019 StandoutNobel
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome
2010
Fcγ receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity
2006
Modulation of Integrin Activation by an Entropic Spring in the β-Knee
2010 StandoutNobel
lincRNAs: Genomics, Evolution, and Mechanisms
2013 Standout
Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy
2004 Standout
Mutations in the NF-κB signaling pathway: implications for human disease
2006
Reactive Oxygen Species Promote TNFα-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatases
2005 Standout
Targeting NF-κB in hematologic malignancies
2006
Mechanisms and impacts of chromosomal translocations in cancers
2012
Transcriptional profiling identifies Id2 function in dendritic cell development
2003
Senescence, apoptosis and therapy — cutting the lifelines of cancer
2003
AP-1: a double-edged sword in tumorigenesis
2003 Standout
Autophagy regulates lipid metabolism
2009 StandoutNature
Lymphoid Malignancies: the dark side of B-cell differentiation
2002
Shared Principles in NF-κB Signaling
2008 Standout
Loss of Net as Repressor Leads to Constitutive Increased c-fos Transcription in Cervical Cancer Cells
2004 StandoutNobel
Hypoxia and Inflammation
2011 Standout
Activation of AID by human T-cell leukemia virus Tax oncoprotein and the possible role of its constitutive expression in ATL genesis
2010
AID Is Required for c-myc/IgH Chromosome Translocations In Vivo
2004 StandoutNobel
AID is required for germinal center–derived lymphomagenesis
2007 StandoutNobel
Control of lymphocyte development by nuclear factor-κB
2005
Large-scale identification and characterization of human genes that activate NF-κB and MAPK signaling pathways
2003
A DNA damage checkpoint response in telomere-initiated senescence
2003 StandoutNature
Notch regulation of lymphocyte development and function
2004
To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis
2003
Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers
2009
Arg1 expression defines immunosuppressive subsets of tumor-associated macrophages
2018
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
2005 StandoutNature
Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
2006
Immunity, Inflammation, and Cancer
2010 Standout
On the Dependency of Cellular Protein Levels on mRNA Abundance
2016 Standout
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma
2003
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Silencing of microRNAs in vivo with ‘antagomirs’
2005 StandoutNature
B cells under influence: transformation of B cells by Epstein–Barr virus
2003
Biology of Hodgkin's lymphoma
2002
BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas
2005
MicroRNA expression profiles classify human cancers
2005 StandoutNatureNobel
Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3
2005 Standout
The Hallmarks of Aging
2013 Standout
The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
2009 Standout
LMP1 signaling and activation of NF-κB in LMP1 transgenic mice
2005
Upstream open reading frames: Molecular switches in (patho)physiology
2010
Part I: Hodgkin's lymphoma—molecular biology of Hodgkin and Reed-Sternberg cells
2003
Cancer-related inflammation
2008 StandoutNature
SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-κB-Dependent Gene Expression and Organismal Life Span
2009
Neoplastic development in plasma cells
2003
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Coordinated binding of NF-κB family members in the response of human cells to lipopolysaccharide
2006
Aberrant NF-κB signaling in lymphoma: mechanisms, consequences, and therapeutic implications
2006
Loss of the B-lineage–specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma
2003
Molecular Pathogenesis of Hodgkin's Lymphoma
2005
eIF3d is an mRNA cap-binding protein that is required for specialized translation initiation
2016 StandoutNatureNobel
The GPIIb/IIIa (integrin αIIbβ3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend
2008
Growth Suppression of Pre-T Acute Lymphoblastic Leukemia Cells by Inhibition of Notch Signaling
2003
Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes
2012 StandoutNobel
Regulation and Function of NF-κB Transcription Factors in the Immune System
2009 Standout
The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
2007 Standout
Decrease in topoisomerase I is responsible for activation-induced cytidine deaminase (AID)-dependent somatic hypermutation
2011 StandoutNobel
Cellular and molecular mechanisms in cancer immune escape: a comprehensive review
2013
A role for Dicer in immune regulation
2006 StandoutNobel
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
2004 Standout
The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance
2008
SATB1 Defines a Subtype of Cutaneous CD30+ Lymphoproliferative Disorders Associated with a T-Helper 17 Cytokine Profile
2018
FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors
2007
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
Genome-Wide Analysis of Gene Expression in T Cells to Identify Targets of the NF-κB Transcription Factor c-Rel
2007
Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas
2005
Chimeric Antigen Receptor Therapy
2018 Standout
Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells
2012
Msx2-interacting nuclear target protein (Mint) deficiency reveals negative regulation of early thymocyte differentiation by Notch/RBP-J signaling
2007 StandoutNobel
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activation
2012
The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor–dependent Mechanisms during Anti-CD20 Antibody Immunotherapy
2004
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation
2020 StandoutNobel
Accumulation of miR-155 and BIC RNA in human B cell lymphomas
2005
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
Polysialic acid governs T-cell development by regulating progenitor access to the thymus
2009 StandoutNobel
Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
2011 StandoutNobel
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Targeting TRAIL Agonistic Receptors for Cancer Therapy
2007
Works of Stephan Mathas being referenced
Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways.
2000
Reprogramming of B Lymphoid Cells in Human Lymphoma Pathogenesis
2006
Common clonal origin of an acute B-lymphoblastic leukemia and a Langerhans' cell sarcoma: evidence for hematopoietic plasticity
2010
Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells
2011
Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappaB
2002
Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells
2004
Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma
2009
Elevated NF-κB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas
2005
Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis
2003
Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma
2002
A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein β and NF-κB activity in Hodgkin and anaplastic large cell lymphomas
2005
In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway
2002
Nuclear Factor κB–dependent Gene Expression Profiling of Hodgkin's Disease Tumor Cells, Pathogenetic Significance, and Link to Constitutive Signal Transducer and Activator of Transcription 5a Activity
2002
Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3α
2008
Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease
2002
Constitutive NF-κB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells
2001
c-FLIP Mediates Resistance of Hodgkin/Reed-Sternberg Cells to Death Receptor–induced Apoptosis
2004
Overexpression of I Kappa B Alpha Without Inhibition of NF-κB Activity and Mutations in the I Kappa B Alpha Gene in Reed-Sternberg Cells
1999
Overexpression of I Kappa B Alpha Without Inhibition of NF-κB Activity and Mutations in the I Kappa B Alpha Gene in Reed-Sternberg Cells
1999